HK Stock Market Move | METIS TECHBIO-P(07666) rose more than 4% in the morning. The company reached a cooperation agreement with Gravel Bio on immune-targeted LNP technology.

METIS TECHBIO-P (07666) rose more than 4% in the morning, as of the time of writing, it has risen by 3.5% to 22.46 Hong Kong dollars, with a trading volume of 62.9567 million Hong Kong dollars. On the news front, Jitai Technology announced that it has officially signed a comprehensive technical cooperation strategic agreement with SandBioscience, a tumor immunotherapy cell treatment company. The two parties will cooperate on the delivery technology of immune-targeted lipid nanoparticles (LNPs) to promote the research and development and translation of new generation in vivo immune therapy products. It is reported that this collaboration relies on Jitai Technology's self-developed global first AI nano delivery platform NanoForge, which is another important milestone empowered by the platform for the OpenCGT project. Up to now, Jitai Technology has achieved precise targeted delivery to eight key organs and tissues in the human body relying on NanoForge, with pipelines covering multiple fields such as tumors, immune systems, central nervous systems, respiratory systems, cardiovascular systems, muscles, and metabolic diseases. A total of 224 patent applications have been submitted, with 52 patents granted.